The DOI matches its Crossref record, with a small difference in title or year; 100 of the 102 references it cites were found in a registry or an index.
Investigation, treatment and monitoring of late-onset hypogonadism in males
Open accessAbstract
Demographic data clearly demonstrate that the percentage of the population in the older age group is increasing. Androgen deficiency in the aging male has become a topic of increasing interest and debate throughout the world. Cross-sectional and longitudinal data indicate that the testosterone falls progressively with age and that a significant percentage of men over the age of 60 years have serum testosterone levels that are below the lower limits of young adult (age 20–30 years) men (1, 2, 3, 4). The principal questions raised by these observations are whether older hypogonadal men will benefit from testosterone treatment and what will be the risks associated with such intervention. The past decade has brought evidence of benefit of androgen treatment of hypogonadal men on multiple target organs and the recent studies show short-term beneficial effects of testosterone in older men that are similar to those in younger men. This has been comprehensively reviewed and summarized by the Institute of Medicine in ‘Testosterone and Aging: Clinical Research Directions’ (5). Long-term data on the effects of testosterone treatment in the older population are limited mainly to effects on body composition and bone mass (6, 7, 8, 9, 10, 11). Key questions of the effects of testosterone on patient reported outcomes and functional benefits that may retard physical or mental frailty of the elderly or improve the quality of life are not yet available. Specific risk data on the prostate and cardiovascular systems are needed. Recent guidelines for the testosterone treatment of younger hypogonadal men are available from professional societies (12, 13, 14). Recommendations on the diagnosis, treatment, and monitoring of late-onset hypogonadism (LOH) were published by International Society for the Study of Aging Male (ISSAM) in 2002 (15). In 2005, a writing committee formed by the International Society of Andrology (ISA), the ISSAM, and the European Association of Urology (EAU) prepared a set of recommendations specifically on the ‘Investigation, treatment and monitoring of LOH’. In order to reach a large audience, these recommendations were published in the International Journal of Andrology, the Journal of Andrology, the Aging Male, and European Urology (16, 17, 18, 19). In view of the growing interest from practitioners on the treatment of older men with testosterone, the ISA, ISSAM, EAU, European Academy of Andrology, and American Society of Andrology convened meetings of the writing group with expert representatives from each of the societies. The writing group membership from 2005 was expanded to include additional urologists. Members of the writing group met in Berlin 2007, Toronto 2007, and Tampa 2008 to revise these recommendations. There was no corporate funding or support for the development of these recommendations. The revised recommendations are supported by a selection of appropriate references and categorized by the level of evidence and grade of recommendation according to the US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research (1992; Table 1). Level of evidence and grade of recommendation utilized in the recommendations. Level of evidence and grade of recommendation utilized in the recommendations. To ensure broad outreach to multidisciplinary audiences, these recommendations are published in several journals simultaneously. LOH, also referred to as age-associated testosterone-deficiency syndrome (TDS), is a clinical and biochemical syndrome associated with advancing age and characterized by symptoms and a deficiency in serum testosterone levels (below the young healthy adult male reference range) (16, 17, 18, 19, 20). This condition may result in significant detriment in the quality of life and adversely affect the function of multiple organ systems. 2.1. At present, the diagnosis of treatable hypogonadism requires the presence of symptoms and signs suggestive of testosterone deficiency (Level 3, Grade A) (12, 16, 17, 18, 19). The symptom most associated with hypogonadism is low libido (Level 3, Grade A) (21, 22). Other manifestations of hypogonadism include: erectile dysfunction, decreased muscle mass and strength, increased body fat, decreased bone mineral density and osteoporosis, and decreased vitality and depressed mood. None of these symptoms are specific to the low androgen state but may raise suspicion of testosterone deficiency. One or more of these symptoms must be corroborated with a low serum testosterone level (Level 3, Grade A) (1, 23, 24, 25). 2.2. Questionnaires such as Aging Male Symptom Score (AMS) (26, 27) and Androgen Deficiency in Aging Men (ADAM) (28) are not recommended for the diagnosis of hypogonadism because of low specificity (Level 3, Grade B) (24, 29, 30). 3.1. In patients at risk or suspected of hypogonadism, a thorough physical and biochemical work-up is necessary (Level 4, Grade A). Transient decreases of serum testostero
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies have also demonstrated increased associations between fT and other comorbid conditions, including depression and hypogonadal symptoms.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [97]
In the citing paper
“There is a degree of consensus that elderly men with serum testosterone clearly below the reference ranges and persistent clear clinical signs of hypogonadism may justifiably be treated (98, 99)”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Self-citationJOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
The Practice Committee of the American Society for Reproductive Medicine
Birmingham, A. (2006) · Cited by 1,925
Journal of the American Geriatrics Society
(1976) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1976.tb03307.x · Cited by 1,309
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Gray, A., Feldman, H. A., McKinlay, J. B., & Longcope, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,104
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Self-citationAssessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chen, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 941
Self-citationWu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1972 · Cited by 939
Self-citation
Flagged first, then by citations
2 of the 102 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- McConnell JD Prostatic growth: new insights into hormonal regulation British Journal of Urology 76 Suppl 1 1995 5 10 7544215
- Nieschlag E Behre HM Testosterone: Acion, Deficiency, Substitution edn. 3. 2004 Cambridge University Press Cambridge
Cited by
Sorted by citations
Items 501–600 of 868
Salonia, A., Andrea Gallina, A., Abdollah, F., Briganti, A., Umberto Capitanio, A., Suardi, N. R., Ferrari, M., Raber, M., Colombo, R., Freschi, M., et al. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0761-5 · Cited by 10
Lamberts, S. W. J., & van den Beld, A. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00027-7 · Cited by 10
Perspectives for metabolomics in testosterone replacement therapy
Haring, R. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0119 · Cited by 10
Lee, K. S., Lee, E. K., Kim, S. Y., Kim, T. H., & Kim, H. P. (2015) · Korean Journal of Food Science and Technology · doi:10.9721/kjfst.2015.47.4.492 · Cited by 10
Erectile dysfunction and hypogonadism (low testosterone).
Barkin, J. (2011) · PubMed · Cited by 10
Résultats fonctionnels et prise en charge des troubles fonctionnels après prostatectomie totale
Salomon, L., Droupy, S., Yiou, R., & Soulie, M. (2015) · The French Journal of Urology · doi:10.1016/j.purol.2015.07.013 · Cited by 10
Applying machine learning techniques to the identification of late-onset hypogonadism in elderly men
Lu, T., Hu, Y., Tsai, C., Liu, S., & Chen, P.-L. (2016) · SpringerPlus · doi:10.1186/s40064-016-2531-8 · Cited by 10
Testosterone for ‘late-onset hypogonadism’ in men?
(2010) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2010.01.0004 · Cited by 10
Okawara, M., Tateishi, S., Horie, S., Yasui, T., & Fujino, Y. (2024) · Industrial Health · doi:10.2486/indhealth.2024-0168 · Cited by 11
King, B., Natale, C., & Hellstrom, W. J. G. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.009 · Cited by 9
Self-citationCirculating sex steroids and prostate cancer: introducing the time-dependency theory
Salonia, A., Abdollah, F., Umberto Capitanio, A., Suardi, N. R., Andrea Gallina, A., Castagna, G., Clementi, M. C., Briganti, A., Rigatti, P., & Montorsi, F. (2013) · World Journal of Urology · doi:10.1007/s00345-012-1009-8 · Cited by 9
Transversal European survey on testosterone deficiency diagnosis
Behre, H. M., Christin‐Maître, S., Morales, A. M., & Tostain, J. (2012) · The Aging Male · doi:10.3109/13685538.2012.655704 · Cited by 9
Self-citationInvestigating the basis of sexual dysfunction during late-onset hypogonadism
Tharakan, T., Miah, S., Jayasena, C. N., & Minhas, S. (2019) · F1000Research · doi:10.12688/f1000research.16561.1 · Cited by 9
Zhou, B., Hu, J., Sun, L., Wang, O., Jiang, Y., Xia, W., Xing, X., & Li, M. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.12.013 · Cited by 9
Trends in testosterone prescription amongst medical specialties: a 5-year CMS data analysis
Carter, I. V., Callegari, M., Jella, T. K., Mahran, A., Cwalina, T. B., Muncey, W. W., Loeb, A., & Thirumavalavan, N. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-021-00497-6 · Cited by 9
Xu, P., Zeng, R., Wan, Q., Xie, Y., Liu, X., An, S., Jiang, J., Yang, J., Zhou, Y., & Shen, X. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112249 · Cited by 9
Horie, S., Hisasue, S., Nakao, M., Ide, H., China, T., Nagae, M., Saito, K., Isotani, S., Yamaguchi, R., Muto, S., et al. (2013) · The Aging Male · doi:10.3109/13685538.2013.801436 · Cited by 9
Ferrandis-Cortés, C., Martínez-Jabaloyas, J. M., Calzadilla, N. D., Hernández-Medina, J. A., & Chuan-Nuez, P. (2013) · Urologia Internationalis · doi:10.1159/000348791 · Cited by 9
Endocrine Aspects of Healthy Brain Aging
Bassil, N., & Morley, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.12.004 · Cited by 9
Self-citationTestosterone-deficiency as a risk factor for hip fracture in elderly men
Torremadé-Barreda, J., Tolrà, J. R., Román-Romera, I., Padró‐Miquel, A., Rius-Moreno, J., & Miranda, E. F. (2013) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2012.06.005 · Cited by 9
Déficit de testosterona como factor de riesgo de fractura de cadera en hombres de edad avanzada
Torremadé-Barreda, J., Tolrà, J. R., Román-Romera, I., Padró‐Miquel, A., Rius-Moreno, J., & Miranda, E. F. (2012) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2012.06.009 · Cited by 9
Pepene, C. E., Crişan, N., & Coman, I. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i4.15365 · Cited by 9
Sexualité et cancer de la prostate
Droupy, S., Alsaid, B., Lechevallier, E., Colson, M., & Giuliano, F. (2013) · The French Journal of Urology · doi:10.1016/j.purol.2013.03.011 · Cited by 9
Jones, T. H. (2009) · BMJ · doi:10.1136/bmj.b352 · Cited by 9
Muti, N. D., Tirabassi, G., Lamonica, G. R., Lenzi, A., & Balercia, G. (2014) · Andrologia · doi:10.1111/and.12339 · Cited by 8
Florvaag, A., Oberle, V., Fritzenwanger, M., Kretschmar, D., Betge, S., Goebel, B., Barz, D., Ferrari, M. W., Figulla, H. R., Franz, M., et al. (2012) · The Aging Male · doi:10.3109/13685538.2012.702361 · Cited by 8
Clinical Update on Nursing Home Medicine: 2014
Messinger‐Rapport, B. J., Gammack, J. K., Little, M. O., & Morley, J. E. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.09.001 · Cited by 8
Self-citationRastrelli, G., Corona, G., Bandini, E., Strada, C., Maseroli, E., Ricca, V., Faravelli, C., Mannucci, E., & Maggi, M. (2012) · International Journal of Impotence Research · doi:10.1038/ijir.2012.33 · Cited by 8
Late-onset hypogonadism or ADAM: diagnosis
Martits, A., Costa, E., Nardi, A., Nardozza, A., Faria, G., Facio, F., & Bernardo, W. (2014) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.60.04.003 · Cited by 8
Steggink, L. C., van Beek, A. P., Boer, H., Meijer, C., Lubberts, S., Oosting, S. F., de Jong, I. J., van Ginkel, R. J., Lefrandt, J. D., Gietema, J. A., et al. (2019) · Andrology · doi:10.1111/andr.12581 · Cited by 8
Prevalence of Age-Associated Testosterone Deficiency Syndrome in Indian Population
Yadav, G. K., Pahwa, M., Singh, M., Tyagi, V., & Chadha, S. (2019) · Advances in Urology · doi:10.1155/2019/2468926 · Cited by 8
Bai, J., Xie, J., Xing, Y., Wang, L., Xie, J., Yang, F., Liu, T., Liu, M., Tang, J., Yi, Z., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.005 · Cited by 10
Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism
Kamalanathan, S., Ambigapathy, J. S., Sahoo, J., Kumar, R., & Perumal, N. L. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_69_20 · Cited by 8
Qin, X., Zhang, H., Ye, D., Yao, X., Zhang, S., & Dai, B. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00078.x · Cited by 8
Vignera, S. L., Condorelli, R. A., Tumino, D., Mauro, M. D., Vicari, E. S. D., & Calogero, A. E. (2012) · International Journal of Impotence Research · doi:10.1038/ijir.2012.7 · Cited by 8
Testosterone supplementation and prostate cancer, controversies still exist.
Drewa, T. A., & Chłosta, P. (2010) · PubMed · Cited by 8
Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism
Kim, J. W., & Moon, D. G. (2011) · Korean journal of urology · doi:10.4111/kju.2011.52.11.725 · Cited by 8
Tirabassi, G., Muscogiuri, G., Colao, A. A. L., & Balercia, G. (2015) · Endocrine Practice · doi:10.4158/ep151064.or · Cited by 8
de Sena, A. D. S. M., Vargas, R. A., de Souza, D. B., Costa, W. S., & Sampaio, F. J. B. (2015) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020150070000005 · Cited by 8
The treatment of late-onset hypogonadism
Üçer, O., & Gumus, B. (2014) · Urology Research and Practice · doi:10.5152/tud.2013.97752 · Cited by 8
Sigalos, J. T., Pastuszak, A. W., & Khera, M. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.10.011 · Cited by 10
Clavell-Hernández, J., & Wang, R. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.17050 · Cited by 8
Why Do We Need New Markers for Male Hypogonadism and How Seminal Proteomics Might Solve the Problem?
Grande, G., Milardi, D., Baroni, S., Urbani, A., & Pontecorvi, A. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200505214021 · Cited by 9
Free testosterone levels and implications on clinical outcomes in elderly men
Doğu, B. B., Özkayar, N., Halil, M. G., Cankurtaran, M., Ülger, Z., Tezcan, E., Gürlek, A., & Arıoğul, S. (2008) · Aging Clinical and Experimental Research · doi:10.1007/bf03324771 · Cited by 8
Botto, H., Neuzillet, Y., Lebrét, T., Camparo, P., Molinié, V., & Raynaud, J. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.023 · Cited by 8
Anaissie, J. E., Pastuszak, A. W., & Khera, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816665-9.00012-3 · Cited by 8
Scala, A., Gender Incongruence Interdisciplinary Group, Graziani, A., Vianello, F., Ferlin, A., & Garolla, A. (2024) · Minerva Endocrinology · doi:10.23736/s2724-6507.24.04171-x · Cited by 7
Li, B., Chen, C., Chen, Z., Ren, Q., Pan, N., He, X., Wang, M., Ai, X., Zhong, Y., Xiang, Y., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001557 · Cited by 8
Current state of practice regarding testosterone supplementation therapy in men with prostate cancer
Kovac, J. R., Pan, M. M., Lipshultz, L. I., & Lamb, D. J. (2014) · Steroids · doi:10.1016/j.steroids.2014.07.004 · Cited by 7
Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma
Ralla, B., Magheli, A., Wolff, I., Erber, B., Goranova, I., Friedersdorff, F., Hinz, S., Kempkensteffen, C., Miller, K., & Busch, J. F. (2016) · Urologia Internationalis · doi:10.1159/000450652 · Cited by 7
Afshar, M., Patel, H., Jain, A., Kumar, A., Patel, P., James, N. D., & Porfiri, E. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1609355 · Cited by 7
Uso da testosterona no envelhecimento masculino
Calixto, I. T., & Prazeres, T. C. M. M. (2019) · Revista de Investigação Biomédica · doi:10.24863/rib.v10i3.315 · Cited by 7
Nishio, R., Takeshita, A., Uchida, T., Takashi, H., Sakamoto, K., Shimizu, Y., Arai, M., Tatsushima, K., Fukuhara, N., Okada, M., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej20-0596 · Cited by 7
Complaint of insomnia as a predictor of aging symptoms in males at a men’s health clinic
Chiu, Y., Chu, C., Chen, Y., Jiang, J.-R., Chau, Y., Hsu, S., Hsieh, M.-L., Chen, C.-L., & Chen, C.-Y. (2011) · The Aging Male · doi:10.3109/13685538.2011.605185 · Cited by 7
Dysfonctions sexuelles après irradiation pour cancer de la prostate
Droupy, S. (2010) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2010.07.223 · Cited by 7
Martínez-Jabaloyas, J. M., Zaragoza, A. Q., Ferrandis-Cortés, C., Queipo-Zaragozá, J. A., Gil‐Salom, M., & Chuan-Nuez, P. (2011) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2011.04.006 · Cited by 7
The Association of Free Testosterone Levels in Men and Lifestyle Factors and Chronic Disease Status
Cardarelli, R., Singh, M., Meyer, J., Balyakina, E., Perez, O., & King, M. R. (2014) · Journal of Primary Care & Community Health · doi:10.1177/2150131913520234 · Cited by 7
Absorption of Testosterone Gel 1% (Testim) from Three Different Application Sites
Guay, A. T., Smith, T. M., & Offutt, L. A. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01366.x · Cited by 7
Saad, F., Haider, A., Giltay, E. J., & Gooren, L. J. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.081 · Cited by 7
Self-citationTirabassi, G., Corona, G., Falzetti, S., Muti, N. D., Maggi, M., & Balercia, G. (2016) · International Journal of Endocrinology · doi:10.1155/2016/5083569 · Cited by 7
Clinical Update on Nursing Home Medicine: 2011
Messinger‐Rapport, B. J., Morley, J. E., Thomas, D. R., & Gammack, J. K. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.08.007 · Cited by 7
Self-citationWistuba, J., Nieschlag, E., Semjonow, A., Sandhowe‐Klaverkamp, R., Friderichs-Gromoll, S., Zitzmann, M., Simoni, M., & Luetjens, C. M. (2012) · Urologia Internationalis · doi:10.1159/000335209 · Cited by 7
Self-citationPathophysiology of the androgen receptor
Hiort, O., Werner, R., & Zitzmann, M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.004 · Cited by 7
Burns, P. R., Kim, E. D., Ruff, D. D., & Seftel, A. D. (2015) · American Journal of Men s Health · doi:10.1177/1557988315609684 · Cited by 7
Hypothalamo-Pituitary Dysfunction in Patients With Chronic Subdural Hematoma
Hána, V., Kosák, M., Masopust, V., Netuka, D., Lacinová, Z., Kršek, M., Marek, J., & Pecen, L. (2012) · Physiological Research · doi:10.33549/physiolres.932290 · Cited by 7
Challenges in the Diagnosis of the Right Patient for Testosterone Replacement Therapy
Wang, C. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.08.002 · Cited by 7
Self-citationShould Hypogonadal Men With Prostate Cancer Receive Testosterone?
Morgentaler, A., & Morales, Á. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.07.010 · Cited by 6
Influence of vitamin D levels on the cardiovascular profile of hypogonadal men
Tirabassi, G., Cutini, M., Salvio, G., Cerqueni, G., Lenzi, A., & Balercia, G. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0671-5 · Cited by 6
Majumdar, S., Mukherjee, J. J., Ray, S., Goswami, S., Jude, E. B., Biswas, A. K., Hanumanthu, A., John, M., Sinha, B., Ghosal, S., et al. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102191 · Cited by 8
Biomedicine: electrospun nanofibrous hormonal therapies through skin/tissue—a review
Özen, İ., & Wang, X. (2021) · International Journal of Polymeric Materials · doi:10.1080/00914037.2021.1985493 · Cited by 6
Hohl, A., & Ronsoni, M. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_15 · Cited by 6
Yu, Y., Wang, Y., Xu, L., Li, W., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1319582 · Cited by 6
Barhouse, P. S., Albright, J. A., Rebello, E., Chang, K., Quinn, M. S., Daniels, A. H., Arcand, M. A., & Gil, J. A. (2024) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2024.01.018 · Cited by 6
Androgen deficiency syndrome in older people
Lee, Y. (2014) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12114 · Cited by 6
Prevalencia de comorbilidades en pacientes con disfunción eréctil
Martínez-Jabaloyas, J. M. (2012) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2012.04.003 · Cited by 6
Martínez-Jabaloyas, J. M., Zaragoza, A. Q., Ferrandis-Cortés, C., Queipo-Zaragozá, J. A., Gil‐Salom, M., & Chuan-Nuez, P. (2011) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2011.04.010 · Cited by 6
Testosterone deficiency and treatment in older men: definition, treatment, pitfalls
Zitzmann, M. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.96 · Cited by 6
Bessède, T., Joly, F., & Lebrét, T. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1440 · Cited by 6
Clinical Update on Nursing Home Medicine: 2012
Messinger‐Rapport, B. J., Cruz‐Oliver, D. M., Thomas, D. R., & Morley, J. E. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.06.006 · Cited by 6
Self-citationPoniatowska, G., Michalski, W., Kucharz, J., Jońska‐Gmyrek, J., Wieszczy, P., Nietupski, K., Demkow, T., Dedecjus, M., Sadowska, M., Kalinowski, T., et al. (2020) · Medical Oncology · doi:10.1007/s12032-020-01407-4 · Cited by 6
Smelser, W., Randall, J. H., Caldwell, J., Glavin, K., Lee, E. K., Nangia, A. K., & Holzbeierlein, J. M. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.12.013 · Cited by 6
Sexual Dysfunction in Chronic Kidney Disease
Johansen, K. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00037-1 · Cited by 6
Li, Y.-R., Tsao, S., Chen, C., Hou, C., Tsui, K.-H., Juang, H., & Lin, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226808 · Cited by 6
Neuzillet, Y., Raynaud, J., Lebrét, T., Pichon, A., Radulescu, C., Molinié, V., & Botto, H. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0005 · Cited by 6
The management of genitourinary war injuries: a multidisciplinary consensus
Sharma, D. M., & on behalf of the Genitourinary Working Group (Trauma) (2013) · Journal of the Royal Army Medical Corps · doi:10.1136/jramc-2013-000029 · Cited by 6
Farajdokht, F., Farhoudi, M., Majdi, A., Zamanlu, M., Sadigh‐Eteghad, S., Vahedi, S., & Mahmoudi, J. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.006 · Cited by 6
Testosterone Deficiency: A Common, Unrecognised Syndrome?
Schulman, C. C., Fusco, F., Morales, A. M., Tostain, J., Vendeira, P., & Zitzmann, M. (2009) · European Urology Supplements · doi:10.1016/j.eursup.2009.05.003 · Cited by 6
Self-citationMortality Associated to Late-Onset Hypogonadism: Reasons Not to Treat With Testosterone?
Kaufman, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1103 · Cited by 6
Self-citationWang, C., Yang, K., Gao, F., Min, Z., & Fu, X. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01456-2 · Cited by 5
Self-citationMale hypogonadism and testosterone replacement therapy
Seal, L. (2013) · Medicine · doi:10.1016/j.mpmed.2013.07.010 · Cited by 5
Why Have the Complications of Diabetes Mellitus Declined Over the Past 30 Years?
Morley, J. E. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.04.022 · Cited by 5
Self-citationHypogonadism and visceral obesity in men are full–fledged components of the metabolic syndrome
Troshina, E. A., & Terekhov, Р. A. (2023) · Obesity and metabolism · doi:10.14341/omet12980 · Cited by 5
Halmenschlager, G., Rhoden, E. L., & Riedner, C. E. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-0066-z · Cited by 5
Wu, H., Lee, C., Chen, C., Tsai, I., & Sun, C. (2012) · Journal of Andrology · doi:10.2164/jandrol.112.016360 · Cited by 5
Reproductive function in middle-aged males: healthy men versus male partners of infertile couples
Ausmees, K., Mändar, R., Korrovits, P., Žarkovski, M., Timberg, G., & Punab, M. (2012) · Andrologia · doi:10.1111/and.12055 · Cited by 5
Friedersdorff, F., Manus, P., Miller, K., Lein, M., Jung, K., & Stephan, C. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.02.002 · Cited by 5
Holm, A. S., & Fredrikson, M. G. (2010) · The Aging Male · doi:10.3109/13685538.2010.518177 · Cited by 5
Testosterone Replacement Therapy: Who to Evaluate, What to Use, How to Follow, and Who is at Risk?
Afiadata, A., & ELLSWORTH, P. I. (2014) · Hospital Practice · doi:10.3810/hp.2014.12.1160 · Cited by 5
Testosterone replacement therapy for physician assistants and nurse practitioners
Ramos, L., Patel, A. S., & Ramasamy, R. (2018) · Translational Andrology and Urology · doi:10.21037/tau.2017.12.09 · Cited by 7
Taşkapu, H. H., Sönmez, M. G., Kılınç, M. T., Altınkaya, N., Aydın, A., & Balasar, M. (2020) · Andrologia · doi:10.1111/and.13759 · Cited by 5
Metadata
- Authors
- Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J.-J., Lunenfeld, B., Morales, A., Morley, J. E., Schulman, C., Thompson, I. M., Weidner, W., & Wu, F. C. W.
- Affiliations
- University of California, Los Angeles (US)
- University of Münster (DE)
- University Hospital in Halle (DE)
- Tulane University (US)
- Vrije Universiteit Amsterdam (NL)
- Ghent University Hospital (BE)
- University of Liège (BE)
- Bar-Ilan University (IL)
- St. Louis VA Medical Center (US)
- Université Libre de Bruxelles (BE)
- The University of Texas at San Antonio Health Science Center (US)
- Justus-Liebig-Universität Gießen (DE)
- Manchester Royal Infirmary (GB)
- Corresponding author
- Wang, C
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11
- Volume
- 159
- Issue
- 5
- Pages
- 507-514
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- PMC
- PMC2754376
- OpenAlex
- W2097830439
- Cited by
- 867
- References
- 102
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 13 · 2023: 15 · 2022: 24 · 2021: 25 · 2020: 31 · 2019: 33 · 2018: 22 · 2017: 39 · 2016: 43 · 2015: 58 · 2014: 88 · 2013: 89 · 2012: 106
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Journal of Endocrinology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- andropause, male hypogonadism, testosterone replacement therapy, older men, androgen deficiency, prostate cancer risk, cardiovascular risk, treatment monitoring, quality of life, frailty, body composition, bone mass, European Association of Urology
- MeSH terms
- Aging, Endocrinology, Europe, Humans, Hypogonadism, Male, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
